Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.
Saved in:
| Title: | Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. |
|---|---|
| Authors: | Avet C; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Mancini A; Domain Therapeutics North America, Montréal, Canada., Breton B; Domain Therapeutics North America, Montréal, Canada., Le Gouill C; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Hauser AS; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Normand C; Domain Therapeutics North America, Montréal, Canada., Kobayashi H; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Gross F; Domain Therapeutics North America, Montréal, Canada., Hogue M; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Lukasheva V; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., St-Onge S; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Carrier M; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Héroux M; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada., Morissette S; Domain Therapeutics North America, Montréal, Canada., Fauman EB; Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, United States., Fortin JP; Pfizer Global R&D, Cambridge, United States., Schann S; Domain Therapeutics, Illkirch-Strasbourg, France., Leroy X; Domain Therapeutics, Illkirch-Strasbourg, France., Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Bouvier M; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada. |
| Source: | ELife [Elife] 2022 Mar 18; Vol. 11. Date of Electronic Publication: 2022 Mar 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35302493 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Avet+C%22">Avet C</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Mancini+A%22">Mancini A</searchLink>; Domain Therapeutics North America, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Breton+B%22">Breton B</searchLink>; Domain Therapeutics North America, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Le+Gouill+C%22">Le Gouill C</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Hauser+AS%22">Hauser AS</searchLink>; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Normand+C%22">Normand C</searchLink>; Domain Therapeutics North America, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Kobayashi+H%22">Kobayashi H</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Gross+F%22">Gross F</searchLink>; Domain Therapeutics North America, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Hogue+M%22">Hogue M</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Lukasheva+V%22">Lukasheva V</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22St-Onge+S%22">St-Onge S</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Carrier+M%22">Carrier M</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Héroux+M%22">Héroux M</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Morissette+S%22">Morissette S</searchLink>; Domain Therapeutics North America, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Fauman+EB%22">Fauman EB</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Fortin+JP%22">Fortin JP</searchLink>; Pfizer Global R&D, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Schann+S%22">Schann S</searchLink>; Domain Therapeutics, Illkirch-Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Leroy+X%22">Leroy X</searchLink>; Domain Therapeutics, Illkirch-Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Gloriam+DE%22">Gloriam DE</searchLink>; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Bouvier+M%22">Bouvier M</searchLink>; Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2022 Mar 18; Vol. 11. <i>Date of Electronic Publication: </i>2022 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35302493 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.74101 Languages: – Code: eng Text: English Titles: – TitleFull: Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Avet C – PersonEntity: Name: NameFull: Mancini A – PersonEntity: Name: NameFull: Breton B – PersonEntity: Name: NameFull: Le Gouill C – PersonEntity: Name: NameFull: Hauser AS – PersonEntity: Name: NameFull: Normand C – PersonEntity: Name: NameFull: Kobayashi H – PersonEntity: Name: NameFull: Gross F – PersonEntity: Name: NameFull: Hogue M – PersonEntity: Name: NameFull: Lukasheva V – PersonEntity: Name: NameFull: St-Onge S – PersonEntity: Name: NameFull: Carrier M – PersonEntity: Name: NameFull: Héroux M – PersonEntity: Name: NameFull: Morissette S – PersonEntity: Name: NameFull: Fauman EB – PersonEntity: Name: NameFull: Fortin JP – PersonEntity: Name: NameFull: Schann S – PersonEntity: Name: NameFull: Leroy X – PersonEntity: Name: NameFull: Gloriam DE – PersonEntity: Name: NameFull: Bouvier M IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 03 Text: 2022 Mar 18 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 11 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |